Globular adiponectin, acting via AdipoR1/APPL1, protects H9c2 cells from hypoxia/reoxygenation-induced apoptosis

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Park, Min ^a,b   Youn, ByungSoo ^c   Zheng, Xi long ^d   Wu, Donghai ^e   Xu, Aimin ^f   Sweeney, Gary ^a,b  

^a YORK UNIVERSITY   (Canada)

^b Institute Pasteur Korea   (South Korea)

^c AdipoGen Inc   (South Korea)

^d LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^e GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

^f UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CASPASE 3; CELL DNA; CYTOCHROME C; GENE PRODUCT; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROTEIN APPL1; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, RAT; ANTIOXIDANT; APPL1 PROTEIN, RAT; CARRIER PROTEIN; NERVE PROTEIN; OXYGEN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; CYTOSOL; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME RELEASE; GENE EXPRESSION; GENE SILENCING; H9C2 CELL; LASER SCANNING CYTOMETRY; MITOCHONDRION; NICK END LABELING; NONHUMAN; RAT; RECEPTOR BINDING; REOXYGENATION; ANIMAL; DRUG EFFECT; GENETICS; HEART MUSCLE CELL; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; REPERFUSION INJURY; SECRETION;

ADIPONECTIN; ANIMALS; ANNEXIN A5; ANTIOXIDANTS; APOPTOSIS; BASE SEQUENCE; CARRIER PROTEINS; CASPASE 3; CELL HYPOXIA; CELL LINE; CYTOCHROMES C; DNA FRAGMENTATION; GENE KNOCKDOWN TECHNIQUES; MITOCHONDRIA; MYOCYTES, CARDIAC; NERVE TISSUE PROTEINS; OXYGEN; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, ADIPONECTIN; REPERFUSION INJURY; RNA, SMALL INTERFERING;

EID: 79955738387     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019143     Document Type: Article

References (44)

1. Abel ED, Litwin SE, Sweeney G, (2008) Cardiac remodeling in obesity. Physiol Rev 88: 389-419.
2. Habbu A, Lakkis NM, Dokainish H, (2006) The obesity paradox: fact or fiction? Am J Cardiol 98: 944-948.
3. Ouchi N, Shibata R, Walsh K, (2006) Cardioprotection by adiponectin. Trends Cardiovasc Med 16: 141-146.
4. Tao L, Wang Y, Gao E, Zhang H, Yuan Y, et al. (2010) Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ Res 106: 409-417.
5. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, et al. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23: 85-89.
6. Laughlin GA, Barrett-Connor E, May S, Langenberg C, (2007) Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 165: 164-174.
7. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, et al. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. Jama 291: 1730-1737.
8. Kadowaki T, Yamauchi T, Kubota N, (2008) The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582: 74-80.
9. Fang X, Sweeney G, (2006) Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem Soc Trans 34: 798-801.
10. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423: 762-769.
11. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 98: 2005-2010.
12. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF, (2002) Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30). J Biol Chem 277: 29359-29362.
13. Tsao TS, Tomas E, Murrey HE, Hug C, Lee DH, et al. (2003) Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem 278: 50810-50817.
14. Ceddia RB, Somwar R, Maida A, Fang X, Bikopoulos G, et al. (2005) Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48: 132-139.
15. Fang X, Palanivel R, Cresser J, Schram K, Ganguly R, et al. (2010) An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab 299: E721-729.
16. Wang C, Xin X, Xiang R, Ramos FJ, Liu M, et al. (2009) Yin-Yang regulation of adiponectin signaling by APPL isoforms in muscle cells. J Biol Chem 284: 31608-31615.
17. Zhou L, Deepa SS, Etzler JC, Ryu J, Mao X, et al. (2009) Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem 284: 22426-22435.
18. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, et al. (2007) Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56: 1387-1394.
19. Mao X, Kikani CK, Riojas RA, Langlais P, Wang L, et al. (2006) APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8: 516-523.
20. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, et al. (2003) A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111: 1497-1504.
21. Konishi M, Haraguchi G, Ohigashi H, Ishihara T, Saito K, et al. (2011) Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovasc Res 89 (2): 309-19.
22. Skurk C, Wittchen F, Suckau L, Witt H, Noutsias M, et al. (2008) Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy. Eur Heart J 29: 1168-1180.
23. Shibata R, Ouchi N, Walsh K, Murohara T, (2007) Potential of adiponectin as a cardioprotective agent. Future Cardiol 3: 647-656.
24. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, et al. (2005) Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103.
25. Tao L, Gao E, Jiao X, Yuan Y, Li S, et al. (2007) Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115: 1408-1416.
26. Takahashi T, Saegusa S, Sumino H, Nakahashi T, Iwai K, et al. (2005) Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis. J Int Med Res 33: 207-214.
27. Fiorillo C, Ponziani V, Giannini L, Cecchi C, Celli A, et al. (2006) Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts. Cell Mol Life Sci 63: 3061-3071.
28. Shin EJ, Schram K, Zheng XL, Sweeney G, (2009) Leptin attenuates hypoxia/reoxygenation-induced activation of the intrinsic pathway of apoptosis in rat H9c2 cells. J Cell Physiol 221: 490-497.
29. Palanivel R, Fang X, Park M, Eguchi M, Pallan S, et al. (2007) Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes. Cardiovasc Res 75: 148-157.
30. Kelesidis I, Kelesidis T, Mantzoros CS, (2006) Adiponectin and cancer: a systematic review. Br J Cancer 94: 1221-1225.
31. Clerk A, Cole SM, Cullingford TE, Harrison JG, Jormakka M, et al. (2003) Regulation of cardiac myocyte cell death. Pharmacol Ther 97: 223-261.
32. Kitsis RN, Narula J, (2008) Introduction-cell death in heart failure. Heart Fail Rev 13: 107-109.
33. Sharma AK, Dhingra S, Khaper N, Singal PK, (2007) Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. Am J Physiol Heart Circ Physiol 293: H1384-1390.
34. Gustafsson AB, Gottlieb RA, (2007) Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol 292: C45-51.
35. Becker LB, vanden Hoek TL, Shao ZH, Li CQ, Schumacker PT, (1999) Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol 277: H2240-2246.
36. Becker LB, (2004) New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61: 461-470.
37. Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, et al. (1989) Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 65: 607-622.
38. Vanden Hoek T, Becker LB, Shao ZH, Li CQ, Schumacker PT, (2000) Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 86: 541-548.
39. Saito S, Fujiwara T, Matsunaga T, Minagawa K, Fukui K, et al. (2007) Increased Adiponectin synthesis in the visceral adipose tissue in men with coronary artery disease treated with pravastatin: A role of the attenuation of oxidative stress. Atherosclerosis.
40. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J, (2004) Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 47: 249-258.
41. Jung TW, Lee JY, Shim WS, Kang ES, Kim JS, et al. (2006) Adiponectin protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity. Biochem Pharmacol 72: 616-623.
42. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, et al. (2004) Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 94: e27-31.
43. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, et al. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339.
44. Wang Y, Gao E, Tao L, Lau WB, Yuan Y, et al. (2009) AMP-activated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin. Circulation 119: 835-844.